Mymd Pharmaceuticals, Inc.

United States of America

 
Total IP 32
Total IP Rank # 45,053
IP Activity Score 2.1/5.0    17
IP Activity Rank # 49,834
Stock Symbol MYMD (nasdaq)
ISIN US62856X1028
Market Cap. 4.300M  (USD)
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

18 2
5 0
7 0
0
 
Last Patent 2022 - Method of treating diseases of t...
First Patent 2015 - Alkaloid compounds for treating ...
Last Trademark 2021 - MYMD PHARMACEUTICALS
First Trademark 2018 - MYMD-1

Industry (Nice Classification)

Latest Inventions, Goods, Services

2022 Invention Method of treating diseases of the visual system. In some aspects, isomyosmine or a pharmaceutica...
2021 Invention Methods of regulating oxidoreductase activity for treatment of inflammation and age-related disor...
Invention Synthetic cannabinoid compounds for treatment of epilepsy, substance addiction and alzheimer's di...
G/S pharmaceutical research and development
Invention Nutrient composition for improving productivity and yield of hydroponically grown plants. In some...
2020 Invention Method of treating disorders associated with chronic inflammation. In one aspect, a method of tre...
Invention Methods of treating sarcopenia. In some aspects, a method of regulating oxidoreductase activity f...
Invention Method of treating coronavirus. In one aspect, a coronavirus is treated by administering a pharma...
Invention Method of treating viral infections. In one aspect, a method of treating a disorder associated wi...
Invention Method of regulating tumor necrosis factor-alpha (tnf-α) for treating cancers, autoimmune disorde...
2019 Invention Method of treating multiple sclerosis. In one aspect, a method of treating a disorder associated ...
Invention Methods of reversing normal aging process and extending lifespan. In one aspect, a method of alte...
Invention Method of treating cocaine addiction. A pharmaceutical composition containing isomyosmine or a ph...
Invention Pharmaceutical salts of isomyosmine and pharmaceutical compositions containing same. In one aspec...
Invention Synthetic cannabinoid compounds for treatment of substance addiction and other disorders. Cannabi...
Invention Genetically modified cannabis sativa plants and modified cannabinoid compounds for treatment of s...
2018 Invention Genetically modified tobacco. A method of increasing the level of isomyosmine in a tobacco plant...
Invention Genetically modified tobacco. A method of increasing the level of isomyosmine in a tobacco ...
G/S Pharmaceutical preparations for reversing the effects of aging
Invention Methods of treating apoptosis and altering programmed cell death. In one aspect, a method of alte...
Invention Method of treating addictions to opioids. A pharmaceutical composition containing isomyosmine or ...
2017 Invention Method of treating skin disorders. In one aspect, a method of treating a disorder associated wit...
Invention Methods of altering programmed cell death and extending cell life. In one aspect, a method of alt...
Invention Method of treating substance addictions. A pharmaceutical composition containing isomyosmine or a...
Invention Methods of increasing hair growth and improving hair appearance. In one aspect, a method of incre...
2016 Invention Methods of treating diabetes. In one aspect, a method of treating a disorder associated with chro...
Invention Methods of treating cancers, autoimmune disorders, and other conditions associated with chronic i...
Invention Skin care products containing isomyosmine. A skin care product includes isomyosmine or a salt the...
Invention Compositions for e-cigarettes. An e-cigarette composition contains a solvent and from about 0.000...
2015 Invention Alkaloid compounds for treating depression, substance addictions, and indications associated with...